MTCH1 and cervical cancer: In addition, cervical cancer patients with low transcription of MTCH1 had a higher probability of RFS (HR = 5.18 (1.55–17.29), P = 0.0029) (Fig. 1B), suggesting that low expression of MTCH1 possibly benefited cervical cancer patients and improved the prognosis.